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Reflux in infants  
 Abstract 
Reflux and Gastro oesophageal Disease (GORD) in infants is a commonly known condition, yet 
research indicates that it is often over diagnosed and poorly managed. Nurses and health care 
professionals are often the first contact that parents have when concerns about their child’s feeding 
arise. In order to ensure that these infants, children and young people are provided with appropriate 
access to education and management options, it is essential that professionals are equipped with 
knowledge on the differences between Reflux and GORD and what interventions are in the best 
interests of the child and family. This article discusses the common symptoms of Reflux and GORD 




Reflux and gastro- oesophageal reflux disease (GORD) is described as being where stomach 
contents (feeds) and acid are expelled up from the stomach through the lower oesophageal 
sphincter ( cardiac sphincter) into the oesophagus and mouth (Kirby 
etal.2015;Douglas ,2013;Terblanche,, 2010). 
It is important to establish that there are defined differences between Reflux and GORD. 
Reflux is common in infants under one year of age and can be a characteristic of a normal 
gastric function in young infants where the gastrointestinal system is still immature (Douglas 
2013;Bell et al 2018). Reflux in itself presents as regurgitation of milk feeds with little or no 
distress or discomfort, it is expected to resolve independently by one year of age with no 
need for medical intervention (Omari et al, 2002; NICE 2015). GORD is described as being 
reflux that is associated with some degree of oesophageal damage and can impair quality of 
life. GORD  presents with physiological symptoms of pain, discomfort with crying and feed 
aversion, and may result in faltering growth, oesophagitis, aspiration and associated 
respiratory conditions (NICE 2015;Omari et al. 2002;Hua et al, 2014). Reflux is reported to 
affect almost half of all babies under three months of age, the regurgitation of feeds in new-
borns is not unusual and should not raise professional alarm (Hua et al 2014;Kirby et al 
2016).  
However, when this is associated with crying and perceived pain, parents are often 
understandably anxious for their child. Parents often present in Community Baby Clinics, GP 
surgeries, walk in centres and Accident and Emergency departments with concerns that 
their child is in pain and regurgitating or vomiting feeds. 
 Nurses and Health Visitors are most commonly the first health care professionals to be 
presented with these babies and children. Therefore it is essential that all nurses are 
equipped with skills to complete efficient holistic assessments and able to differentiate 
between reflux, GORD or other conditions that affect the comfort and feeding of infants and 
children. Premature babies are more at risk of reflux and GORD, due to health complexities 
that could be affecting feeding (Psaila et al 2014;Omari et al 2002). Equally children with 
neurological conditions, cystic fibrosis and oesophageal atresia  are at increased risk of 
severe GORD (Omari et al, 2002).Children and young people can also be affected by reflux 
and GORD, although this is less common and more often attributed to physical illness, 
medication or obesity.  
Learning Outcomes 
► Differentiate between the symptoms of Reflux and GORD in infants, children and young 
people. 
►Recognise what education and support can be provided to parents and carers to help manage 
symptoms. 
►Develop awareness of the conservative approaches to care that can be provided, and to 
recognise when care needs to be reassessed and alternative management strategies 
considered. 
►understand the rationale behind recommended interventions and explain this to parents and 
carers of infants, children and young people affected by symptoms of reflux and GORD. 
 
Assessment 
As with all nursing assessments a complete and comprehensive approach is required. It is 
important to ascertain any presenting symptoms, feeding patterns and medical histories, 
social circumstances alongside parental concerns and ideas. 
Where some degree of post prandial regurgitation  and non-forceful vomiting is common in 
babies and children, the frequency and volume need clarification, is this affecting growth 
and weight gain ?,are any other symptoms present that could indicate more complex health 
issues ? 
Red Flags 
Symptoms such as 
▪ feed aversion 
▪ weight loss,  
▪choking, 
▪ apnoea, 
▪ irritability,  
▪perceived indicators of pain,  
▪sleeping difficulties 
 ▪any life-threatening occurrences,  
 These need to be assessed to ensure other health complications are excluded and GORD is 
established as a the only possible diagnosis. Premature infants, children with cystic fibrosis, 
oesophageal atresia or neurological impairment are at heightened risk of developing severe 
GORD (Terblanhe 2010; Omari et al 2002; NICE 2015). 
The root cause of any reflux or GORD needs to be established as part of the assessment 
process in order to ensure appropriate management can be initiated (Terblanche, 2010, 
NICE 2017). Investigations are rarely  required unless other alarming factors are identified 
through assessment and examination (NICE 2015;Terblanche 2010;Omari et al 2002;Kirby et 
al 2015). If this process indicates a need for investigations due to severe GORD or to 
eliminate other health complexities, Ph monitoring, gastric motility tests and endoscopy are 
the first actions that are recommended by NICE (2015). 
When other health complications are eliminated, it its then important that the nurse is able 
to recognise where Reflux and GORD differ and is able to support a suitable therapeutic 
approach in the management of the presenting symptoms. 
Common symptoms 
REFLUX GORD 
Post-prandial regurgitation ( can last 3-5 
mins) up to 3 times day in infants 
 More frequent Post-prandial regurgitation 
in infants 
 Non forceful vomiting in infants and 
children 
 Infant settles after feed Back arching  during and after feeds in 
infants 
Completes feed in infants Feed aversion in infants and children 
Attaches to breast or bottle with little 
distress in infants 
Excessive crying during feed in infants 
Comfortable in supine position in infancy Haematemesis 
Strange taste in mouth in children and 
young people ( acid backflow) 
Wriggles and cries in supine position in 
infants 
Heartburn in young people Irritability in infancy 
 Ear ache  in children and young people 
 Worsening asthma in children and young 
people ( or respiratory problems) 
 Aspiration and/or apnoea in infants 
 Faltering growth and/ or weight loss 
 Chest pain in children and young people 
 Hoarseness in children and young people 
 Abdominal pain in children and young 
people 
 Nausea in children and young people 
  
 
Management of Reflux 
Reflux alone with the only presenting symptom being post prandial regurgitation or low 
volume  non forceful vomiting should be managed with education and support for parents 
and the avoidance of medication ( NICE 2015;Hua 2014;Kirby et  al 2015;Douglas 2013). 
 
Non Nutritive sucking 
There is some research that suggests non-nutritive sucking ( use of  a dummy) may help 
inhibit acid production and settle a baby if used directly prior to feeds (Psaila et al, 2014). 
Psaila et al (2014) studied 38 premature infants to identify whether the use of a dummy for 
20-39 minutes before a feed would reduce acid build up and post prandial regurgitation. 
Results indicated that the dummy had a significant effect on reducing the number of Reflux 
episodes but did not effect the time until any episodes passed after a feed. PH monitoring 
was used to evidence the gastric residuals acidic value and supported lower acidity in the 
control group who used the dummy pre feed, these infants were also reported to have 
reduced fussiness at feed times and less episodes of crying. However the research for non-
nutritive sucking is limited and must be considered with the controversial advice on dummy 
use.  
Positioning  
Nursing infants in upright supine  position ( up right, front down on parents/carers chest, 
head resting on shoulder, with parent/carer sat up or standing) is often recommended (NICE 
2015;Bargaouli, Bellaiche and Clerson 2014) to help reduce post prandial regurgitation. It is 
suggested  that this position for 20-30 minutes post feed allows  stomach contents to settle, 
hence reduce the risk of feed and acidic back flow up the oesophagus. To facilitate this 
positon safely, parents and carers needs advice on the optimal position and educated to be 
aware that this is only safe for infants when awake and in parents/carers arms, and not safe 
for  feeding or sleeping positions. It is essential to ensure that parents and carers are  
supported to maintain safe sleeping guidelines in order  to minimise risk of Sudden Infant 
Death Syndrome (Bargaouli, Bellaiche and Clerson 2014; NHS 2018; Hua 2013). 
Volume and Frequency of feeds 
NICE (2015) advise that small frequent feeding will help reduce stomach extension, over full 
stomachs and therefore reduce post prandial regurgitation, feed regurgitation and 
discomfort in infants and young children. Feeding patterns need to be clarified and parents 
of formula fed infants encouraged to offer the same total volume of daily feeds in small 
feeds with increased occurrence, for example if formula fed infant feeds 120 mls every four 
hours, changing to 60mls every two hours can help reduce symptoms of reflux such as 
regurgitation and post feed discomfort. Frequency of feeds for breast fed infants is also 
encouraged to help the infant regulate their feeds, ensure adequate supply and minimise 
symptoms. Parents are often misguided by the belief that infants and children should be fed 
4 hourly, education around stomach capacity of babies and the benefits of feeding more 
regularly can help change these perceptions and provide support to parents in managing 
their child’s  feeding behaviours enabling a reduction in symptoms of Reflux 
(Carroll,Garrsion and Christaskis 2002).  Similar feeding behaviours for children and young 
people is recommended to minimise over fill of the stomach and avoid increased acid 
production, stomach distension and associated pain or vomiting ( RuIgomez et al, 2010). 
 
Use of Feed Thickening Agents 
NICE (2015) advise that if feeding regimes do not make significant improvements and Reflux 
symptoms continue, the use of feed thickeners should be trialled for an initial period of 1-2 
weeks. There are some thickened formula milk preparations available or a thickening agent 
could be used for breastfed babies. If symptoms improve the use of feed thickener can be 
continued and trialled occasionally to see if symptoms have resolved and the thickening 
agents can be discontinued. A study by Kwok, Ohja and Dorling (2017) reviewed 637 infants 
who were using feed thickeners to manage Reflux and GORD symptoms. 95% of the sample 
were reported as having 2 fewer episodes of regurgitation each day and were 2.5 times 
more likely to be asymptomatic when on feeds contained thickening agents. No side effects 
of the thickening agents were reported in any of the sample participants. PH studies were 
performed on the sample and supported the results, representing a reduction in stomach 
acid by 5% in babies who received  feed thickeners. 
Use of Sodium Alginate products 
NICE(2015) advises that as a last line treatment for Reflux, the trial of a sodium alginate 
product such as Gaviscon could be tested. They advise a short trial of 1-2 weeks to assess 
efficacy and to discontinue use if no improvement is symptoms is apparent. Where 
significant reduction of symptoms occurs, NICE (2015) recommend continued use with 
regular trials off treatment to reassess whether symptoms persist or the child has outgrown 
the Reflux. Sodium Alginate products work by providing a barrier on the surface of gastric 
contents and forming a raft, therefore allowing the product to enter the oesophagus rather 
than gastric contents (Malcom et al 2008). 
 Clinical studies (Hua et al 2014;Bell et el 2018; Kirby et al; 2015;Douglas 2013) report that 
the use of Sodium Alginate products merely offer a placebo effect and their use should be 
limited. These products have potential side effects such as increased respiratory infections. 
As they contain high sodium content there is also be an increased risk of renal complications 
such as hypernatremia (Zentilin et al 2005) . 
Corvaglia et al (2011) researched 32 infants who all were symptomatic with Reflux, results  
show that management with a sodium alginate product decreased gastro s reflux in the 
whole sample. Ph monitoring evidenced that infants treated with this product had reduced 
stomach acidity and  less regurgitation that reached the proximal oesophagus, therefore 
showing significant reduction in signs of Reflux. This study offers promising efficacy on the 
use of sodium alginate products, however clinical assessment and education strategies 
should guide its short-term use. 
Managing GORD 
GORD differentiates from Reflux in the severity of its symptoms and its impact on the 
gastro- intestinal tract. GORD affects an infant, child or young persons quality of life and can 
present with serious complications, such as apnoea, aspiration, oesophageal  inflammation 
and damage (oesophagitis)faltering growth. GORD in infancy is often associated with 
excessive crying due to perceived pain, which has a negative effect on continued 
breastfeeding, infant and parent attachment alongside maternal health (Douglas 2013). 
Management of GORD requires intervention from the outset, similar strategies for 
education and support of parents and carers to those recommended in Reflux are guided by 
NICE (2015) in the first instance. Where these are not seen to be effective further medical 
management can be initiated, a trial of 4 weeks is advised to ascertain efficacy, prior to 
reassessment and controlled periods of no treatment to establish the need for continued 
medication. 
H2 Receptor Blockers (H2RA) 
H2 receptor blockers or antagonists such as Ranitidine ( BNF 2018/19), are prescribed for 
extreme symptoms of GORD. These medications block the reaction of histamine within the 
parietal cells in the stomach.  This mechanism decreases the production of acid and reduces 
symptoms of GORD that are caused by excessive acid production. Studies  such as those by 
Zentilin et al (2005) and Corvaglia et al (2011) highlight that these drugs can increase the 
risk of necrotising enterocolitis in low birth weight infants and may increase the risk of 
sepsis in infancy, and should be used with extreme caution and monitoring within infant, 
children and young people.   
Proton Pump Inhibitors (PPI) 
These drugs  such as omeprazole and lansoprazole (BNF 2018/19), is pronounced and long-
lasting reduction of stomach acid. PPIs are classed as the most beneficial  inhibitor of gastric 
acid secretions. PPIs are specifically for treatment of severe GORD, they are generally well 
tolerated although have recognisable side effects such as abdominal pain, nausea and 
vomiting that could be misinterpreted as being ineffective in managing all symptoms of 
GORD. PPIs increase the risk of clostridium difficule ( infection of the colon) and  long-term 
use may increase risk of osteoporosis and bone fractures. Their use in children is minimal 
and directed by medical assessment for severe and potentially life limiting GORD (Davis et al 
2015;NICE 2015). 
Surgical intervention –  Nissen fundoplication 
 In extreme cases where medical management has not resulted in satisfactory weight gain 
and serious concerns continue over a child’s ability to grow, maintain adequate nutrition 
and a healthy life surgery is considered. Nissen Fundoplication’s are rare and often only 
required in infants or children with complications of GORD due to chronic health needs or 
faltering growth. Investigations will be completed prior to surgical intervention and directed 
by surgical teams within acute care. A  Nissen fundoplication is where the lower 
oesophageal sphincter is surgically tightened to reduce risk of any regurgitation from feeds, 
acid or vomiting. This is not usual practice for reflux however in extreme cases of GORD 
provides infants and children the opportunity to be more permanently asymptomatic 
( Rothenberg 2004), with improvements to health and quality of life. 
Supporting parent’s anxiety 
Parents and carers need to be equipped with knowledge and techniques of how to manage 
their child’s crying and possible feed aversion (Scherer et al 2013). The strategies mentioned 
above such as positional adaptations, changes to feed patterns alongside listening and 
professional reassurance may help parents to feel supported and maintain the infant child 
attachment (Hua et al 2015). Excessive crying that is associated with challenging feed 
behaviours can increase parents anxiety, with a negative effect on how their child respond 
and settle (Khoshoo and Thompson 2007). Professional reassurance and guidance must be 
at the centre of all interventions (NICE 2015). 
Summary 
Research suggests that the incidences of diagnosed reflux and GORD is increasing 
exponentially (Bell et al 2017). Kirby et al (2015) reports through an Australian study of 400 
cases of infantile reflux and GORD that over diagnosis is possibly occurring, with heath care 
professionals feeling the need to medically manage rather than treat with a conservative 
approach. 
In order to ensure that infants, children and young people are provided with the best 
possible nursing care, it is essential that all health care practitioners who have contact with 
infants, children and young people are able to complete holistic assessments, differentiate 
between Reflux and GORD and initiate effective education and management plans that 
support both the child and family, reducing the risk of over treatment for Reflux or 
worsening health in ill managed GORD ( Bell et al 2017; Kirby et al 2015;Terblanche 2010). 
CPD Questions 
►Have you ever assessed a child with symptoms of Reflux or GORD ? What was your 
care plan? Can you now identify any different approaches ? 
►Can you identify the differences between Reflux and GORD? Would you feel 
competent in completing a nursing assessment on a child with these symptoms? When 
would you consider referral to another specialist? 
►What do you feel would assist your confidence and care in managing Reflux or GORD 
in infants, children and young people ? How will you achieve this ? 
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